WANBURY
Quarterly Results Analysis [Mar2025]
WANBURY Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹172 Cr | ₹133 Cr | ₹161 Cr | ₹131 Cr | ₹140 Cr | ₹145 Cr | ₹144 Cr | ₹146 Cr |
Expenses | ₹142 Cr | ₹120 Cr | ₹141 Cr | ₹120 Cr | ₹121 Cr | ₹124 Cr | ₹127 Cr | ₹133 Cr |
Operating Income | ₹30 Cr | ₹14 Cr | ₹20 Cr | ₹11 Cr | ₹19 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr |
Other Income | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹6 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹19 Cr | ₹1 Cr | ₹8 Cr | ₹1 Cr | ₹34 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr |
Profit After Tax | ₹20 Cr | ₹1 Cr | ₹8 Cr | ₹1 Cr | ₹34 Cr | ₹10 Cr | ₹7 Cr | ₹5 Cr |
EPS | ₹6.18 | ₹0.37 | ₹2.45 | ₹0.32 | ₹10.27 | ₹3.14 | ₹2.25 | ₹1.43 |
Industry Peers & Returns | 1W | 1M | 1Y |
WANBURY | 0.9% | 24.3% | 110.3% |
SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -2.9% | 17.2% |
DIVIS LABORATORIES | 1.5% | 10.4% | 51.9% |
CIPLA | 2.3% | 1.9% | 2.8% |
TORRENT PHARMACEUTICALS | 1.4% | 1.3% | 17% |
DR REDDYS LABORATORIES | 5.7% | 14.1% | 15.2% |
MANKIND PHARMA | 0.2% | -2.4% | 12.5% |
ZYDUS LIFESCIENCES | 5.1% | 10.9% | -4.4% |
LUPIN | 2% | -2.2% | 27.9% |
WANBURY Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 28.89 % |
Y-o-Y | 23.07 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹172 Cr | 28.89 | |
Dec2024 | ₹133 Cr | -17.21 | |
Sep2024 | ₹161 Cr | 22.94 | |
Jun2024 | ₹131 Cr | -6.19 | |
Mar2024 | ₹140 Cr | -3.94 | |
Dec2023 | ₹145 Cr | 0.72 | |
Sep2023 | ₹144 Cr | -1.25 | |
Jun2023 | ₹146 Cr | - |
WANBURY Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 112.46 % |
Y-o-Y | 59.97 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹30 Cr | 112.46 | |
Dec2024 | ₹14 Cr | -30.31 | |
Sep2024 | ₹20 Cr | 82.33 | |
Jun2024 | ₹11 Cr | -40.75 | |
Mar2024 | ₹19 Cr | -12.42 | |
Dec2023 | ₹21 Cr | 21.92 | |
Sep2023 | ₹17 Cr | 29.94 | |
Jun2023 | ₹13 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 64.88 % |
Y-o-Y | 30.04 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 17.23% | 64.88 | |
Dec2024 | 10.45% | -15.79 | |
Sep2024 | 12.41% | 48.27 | |
Jun2024 | 8.37% | -36.83 | |
Mar2024 | 13.25% | -8.81 | |
Dec2023 | 14.53% | 20.98 | |
Sep2023 | 12.01% | 31.69 | |
Jun2023 | 9.12% | - |
WANBURY Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 1,563.14 % |
Y-o-Y | -39.77 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹20 Cr | 1,563.14 | |
Dec2024 | ₹1 Cr | -84.81 | |
Sep2024 | ₹8 Cr | 673.29 | |
Jun2024 | ₹1 Cr | -96.92 | |
Mar2024 | ₹34 Cr | 227.42 | |
Dec2023 | ₹10 Cr | 39.53 | |
Sep2023 | ₹7 Cr | 57.01 | |
Jun2023 | ₹5 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 1,194.51 % |
Y-o-Y | -51.04 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 11.78 % | 1,194.51 | |
Dec2024 | 0.91 % | -81.69 | |
Sep2024 | 4.97 % | 529.11 | |
Jun2024 | 0.79 % | -96.72 | |
Mar2024 | 24.06 % | 240.79 | |
Dec2023 | 7.06 % | 38.43 | |
Sep2023 | 5.1 % | 58.88 | |
Jun2023 | 3.21 % | - |
WANBURY Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 1,570.27 % |
Y-o-Y | -39.82 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹6.18 | 1,570.27 | |
Dec2024 | ₹0.37 | -84.90 | |
Sep2024 | ₹2.45 | 665.63 | |
Jun2024 | ₹0.32 | -96.88 | |
Mar2024 | ₹10.27 | 227.07 | |
Dec2023 | ₹3.14 | 39.56 | |
Sep2023 | ₹2.25 | 57.34 | |
Jun2023 | ₹1.43 | - |
You may also like the below Video Courses